Literature DB >> 10825060

Primary lamivudine resistance in acute/early human immunodeficiency virus infection.

B Conway1, V Montessori, D Rouleau, J S Montaner, M V O'Shaughnessy, S Fransen, A Shillington, O Weislow, D L Mayers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10825060     DOI： 10.1086/515225

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  3 in total

1.  Prophylactic and therapeutic benefits of short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) administration to newborn macaques following oral inoculation with simian immunodeficiency virus with reduced susceptibility to PMPA.

Authors:  K K Van Rompay; M D Miller; M L Marthas; N A Margot; P J Dailey; D R Canfield; R P Tarara; J M Cherrington; N L Aguirre; N Bischofberger; N C Pedersen
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  Virulence and reduced fitness of simian immunodeficiency virus with the M184V mutation in reverse transcriptase.

Authors:  Koen K A Van Rompay; Tim B Matthews; Joanne Higgins; Don R Canfield; Ross P Tarara; Mark A Wainberg; Raymond F Schinazi; Niels C Pedersen; Thomas W North
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

3.  Analysis of HIV-1 drug resistant mutations by line probe assay and direct sequencing in a cohort of therapy naive HIV-1 infected Italian patients.

Authors:  M C Re; P Monari; I Bon; D Gibellini; F Vitone; M Borderi; M La Placa
Journal:  BMC Microbiol       Date:  2001-11-27       Impact factor: 3.605
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.